|
|
|
|
|
|
|
|
02/04/2009 |
We are pleased to announce that Toxikon Eurpe NV has been qualified by CIR (Crédit d’impôt recherche), part of French government,
that allows a beneficial approach for R&D projects. |
|
02/04/2009 |
Toxikon is pleased to announce that staff members from Toxikon Europe N.V. will be taking part in this year’s Pre-filled Syringes and Advanced Injection Technologies Conference in Piccadilly, London. |
|
|
|
|
|
|
|
10/29/2008 |
Toxikon Europe welcomed more than 1,200 visitors to their open house in Leuven, Belgium on October 5, including Patricia Ceysens, Flemish Minister of Economy, Science, Innovation and Foreign Trade. |
|
|
|
|
|
8/25/2008 |
Toxikon Corporation ranked No. 4,003 among Inc. magazine’s 2008 list of the 5,000 fastest-growing private companies in America. |
|
07/11/2008 |
Dr. Anja Cerstiaens, a study director for Toxikon Europe NV, is scheduled to speak at this year’s Extractables and Leachables conference in Bethesda, Maryland. |
|
|
|
|
|
11/30/2007 |
Toxikon continues to expand Non-GLP Preclinical Discovery Services.Contact our Client Services Department for more information on these or other early stage/proof of concept studies to support your R&D efforts. |
|
2/26/2007 |
Toxikon Corporation celebrates its 30th year in business. |
|
7/25/2006 |
Toxikon Corporation is pleased to announce the opening of technical sales office in India to serve the needs of Asian pharmaceutical and biotechnology organizations. |
|
7/11/2006 |
Toxikon Corporation announces the successful completion of CAP accreditation by the Commission on Laboratory Accreditation of College of American Pathologists. |
|
5/31/2006 |
Toxikon Corporation announces the availability of services for preclinical testing and development of ophthalmic drugs and devices. |
|
5/9/2006 |
Instem's hosted Provantis Solution Chosen by Toxikon as a Result of Side-by-Side Analysis and "Hands-on" User Evaluation of Competing Systems |
|
